SLI
2.039,02
PKT
+0,90
PKT
+0,04
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.07.05 | Nestlé overweight | Lehman Brothers | |
| 29.07.05 | ABB (Asea Brown Boveri) reduce | Jyske Bank | |
| 28.07.05 | Nestlé overweight | Morgan Stanley | |
| 28.07.05 | Holcim halten | Helaba Trust | |
| 28.07.05 | Novartis buy | Merrill Lynch | |
| 29.07.05 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
| 27.07.05 | Nestlé kaufen | Helaba Trust | |
| 27.07.05 | Nestlé overweight | Morgan Stanley | |
| 25.07.05 | Logitech | Euro am Sonntag | |
| 25.07.05 | Logitech Buy | Needham & Co | |
| 17.08.05 | Richemont kaufen | Bank Hofmann | |
| 22.07.05 | Zurich Insurance | DZ-Bank | |
| 22.07.05 | UBS kaufen | Der Aktionärsbrief | |
| 22.07.05 | UBS kaufen | Helaba Trust | |
| 21.07.05 | Novartis halten | National-Bank AG | |
| 21.07.05 | Novartis | Zürcher Kantonalbank | |
| 21.07.05 | Novartis Net Negative | Susquehanna Financial | |
| 20.07.05 | Novartis buy | Banque SYZ & CO | |
| 20.07.05 | Novartis | JRC | |
| 20.07.05 | UBS outperform | Goldman Sachs | |
| 19.07.05 | ABB (Asea Brown Boveri) equal-weight | Morgan Stanley | |
| 18.07.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 15.07.05 | Zurich Insurance | DZ-Bank | |
| 18.07.05 | Novartis buy | Merrill Lynch | |
| 15.07.05 | Novartis kaufen | Hamburger Sparkasse | |
| 15.07.05 | Novartis kaufen | National-Bank AG | |
| 15.07.05 | Nestlé neutral | Bank Sarasin & Cie | |
| 15.07.05 | Novartis akkumulieren | Independent Research | |
| 15.07.05 | Holcim halten | Helaba Trust | |
| 19.07.05 | Novartis buy | Jyske Bank | |
| 14.07.05 | Novartis kaufen | Helaba Trust | |
| 14.07.05 | Novartis buy | SEB | |
| 14.07.05 | Holcim underweight | Morgan Stanley | |
| 14.07.05 | ABB (Asea Brown Boveri) halten | Helaba Trust | |
| 14.07.05 | Novartis akkumulieren | Independent Research | |
| 14.07.05 | Nestlé | Focus Money | |
| 13.07.05 | Novartis neutral | HypoVereinsbank | |
| 13.07.05 | Novartis outperform | Bear Stearns | |
| 12.07.05 | Novartis kaufen | Helaba Trust | |
| 12.07.05 | Novartis in-line | Goldman Sachs |